ANL 30.88 Increased By ▲ 0.20 (0.65%)
ASC 14.38 Decreased By ▼ -0.56 (-3.75%)
ASL 23.70 Decreased By ▼ -0.20 (-0.84%)
AVN 93.60 Increased By ▲ 1.60 (1.74%)
BOP 9.09 Decreased By ▼ -0.05 (-0.55%)
BYCO 9.85 Decreased By ▼ -0.40 (-3.9%)
DGKC 135.10 Decreased By ▼ -0.50 (-0.37%)
EPCL 52.11 Increased By ▲ 2.11 (4.22%)
FCCL 24.15 Decreased By ▼ -0.47 (-1.91%)
FFBL 24.00 Decreased By ▼ -0.25 (-1.03%)
FFL 15.12 Decreased By ▼ -0.48 (-3.08%)
HASCOL 10.74 No Change ▼ 0.00 (0%)
HUBC 84.50 Decreased By ▼ -0.70 (-0.82%)
HUMNL 7.04 Decreased By ▼ -0.31 (-4.22%)
JSCL 24.31 Decreased By ▼ -0.54 (-2.17%)
KAPCO 37.00 Decreased By ▼ -0.85 (-2.25%)
KEL 4.10 Decreased By ▼ -0.05 (-1.2%)
LOTCHEM 14.31 Decreased By ▼ -0.47 (-3.18%)
MLCF 46.51 Decreased By ▼ -0.09 (-0.19%)
PAEL 37.20 Decreased By ▼ -1.05 (-2.75%)
PIBTL 11.64 Decreased By ▼ -0.16 (-1.36%)
POWER 10.30 Decreased By ▼ -0.20 (-1.9%)
PPL 89.83 Decreased By ▼ -0.72 (-0.8%)
PRL 25.40 Decreased By ▼ -0.70 (-2.68%)
PTC 8.76 Decreased By ▼ -0.19 (-2.12%)
SILK 1.41 Increased By ▲ 0.01 (0.71%)
SNGP 37.80 Decreased By ▼ -0.30 (-0.79%)
TRG 138.76 Decreased By ▼ -2.34 (-1.66%)
UNITY 29.34 Decreased By ▼ -2.16 (-6.86%)
WTL 1.52 Decreased By ▼ -0.05 (-3.18%)
BR100 4,884 Decreased By ▼ -52.58 (-1.07%)
BR30 25,127 Decreased By ▼ -276.39 (-1.09%)
KSE100 45,454 Decreased By ▼ -410.61 (-0.9%)
KSE30 18,984 Decreased By ▼ -188.74 (-0.98%)
Business & Finance

Germany expects AstraZeneca to deliver 3mn COVID-19 vaccine doses in February

  • The good news is that if the AstraZeneca vaccine is approved at the end of January, we expect at least 3 million vaccine doses for Germany in February.
  • The government also remained committed to its goal of vaccinating all willing citizens older than 80 years by the end of March, Spahn said.
23 Jan 2021

BERLIN: Germany expects British drugmaker AstraZeneca Plc to deliver 3 million doses of its COVID-19 vaccine in February despite the company's latest production problems, Health Minister Jens Spahn told Bild am Sonntag newspaper.

AstraZeneca informed European Union officials on Friday it would cut deliveries of its COVID-19 vaccine to the bloc by 60% to 31 million doses in the first quarter of the year due to production problems, a senior official told Reuters.

The decrease deals another blow to Europe's COVID-19 vaccination drive after Pfizer Inc and German partner BioNTech slowed supplies of their vaccine to the bloc this week, saying the move was needed because of work to ramp up production.

"The good news is that if the AstraZeneca vaccine is approved at the end of January, we expect at least 3 million vaccine doses for Germany in February," Spahn told Bild am Sonntag in an interview.

Spahn acknowledged this was less than expected. The delay showed the production of vaccines was a much more complex task than some media headlines suggested, he added.

Spahn renewed his promise that the government would be able to make a vaccination offer to all citizens who wanted to get the shot by the summer. "If the expected approvals for further vaccines come, it will stay that way," Spahn said.

The government also remained committed to its goal of vaccinating all willing citizens older than 80 years by the end of March, Spahn said.

The minister rejected criticism that Germany was lacking other countries in its vaccination drive.

"We can make meaningful comparisons in two or three months," Spahn said, adding that Germany had decided to start with vaccinations in nursing homes, which he described as a more complex and time-consuming task.